全球智慧型胰島素筆市場規模、佔有率、成長分析、依產品、依連接類型、依適應症、依最終用戶 - 產業預測 2024-2031

2022年全球智慧胰島素筆市場規模為36.6億美元，預計將從2023年的40.3億美元增至2031年的86.3億美元，預測期（2024-2031）複合年成長率為10% ）。

智慧胰島素筆透過促進糖尿病患者外部注射胰島素，為糖尿病管理提供了卓越的解決方案。這些筆配備了及時提醒和警報等功能，確保定期給藥。其方便用戶使用的設計正在推動其越來越受歡迎。智慧胰島素筆可以輕鬆連接到現有的胰島素筆，從而增強其功能。智慧胰島素筆的市場正在擴大，因為它們能夠及時發出正確胰島素劑量的警報和提醒，並監控錯過的劑量，這對糖尿病患者至關重要。這些設備還可以透過監測特定時間和日期的血糖水平來幫助記錄患者的糖尿病概況。此外，他們還監控胰島素溫度範圍和有效期，以確保患者安全。然而，COVID-19大流行對智慧胰島素筆市場產生了重大負面影響，因為嚴格的封鎖措施和限制行動阻礙了實驗室檢測和糖尿病服務的獲得，從而限制了市場成長。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

全球智慧胰島素筆市場（依產品）

• 市場概況
• 智慧胰島素筆
• 傳統筆的適配器

依連接類型分類的全球智慧胰島素筆市場

• 市場概況
• 藍牙
• USB

依適應症分類的全球智慧胰島素筆市場

• 市場概況
• 1 型糖尿病
• 2型糖尿病

全球智慧胰島素筆市場（依最終用戶）

• 市場概況
• 醫院和診所
• 門診手術中心
• 家庭護理設置

依地區分類的全球智慧胰島素筆市場

• 市場概況
• 北美洲
• 歐洲
• 亞太
• 拉丁美洲
• 和MEA

全球智慧型胰島素筆市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2023 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率 (%), 2023

主要公司簡介

• Emperra GmbH
• Novo Nordisk A/S
• Medtronic plc
• Eli Lilly and Companya
• Sanofi SAa
• Companion Medical Inc.a
• Diabnexta
• Insulet Corporationa
• Pendiq GmbHa
• Digital Medics Pty Ltd.a
• F. Hoffmann-La Roche AGa
• Ypsomed AGa
• Common Sensing Inc.a
• InjexUK Ltd.a
• Diamesco Co., Ltd.a
• Nipro Corporationa
• Jiangsu Delfu Co., Ltd.a
• Wockhardt Ltd.a
• Biocon Ltd.

Global smart insulin pens market size was valued at USD 3.66 billion in 2022 and is expected to rise from USD 4.03 billion in 2023 to reach a value of USD 8.63 billion by 2031, at a CAGR of 10% during the forecast period (2024-2031).

Smart insulin pens offer a superior solution for managing diabetes by facilitating the external administration of insulin to diabetic patients. These pens are equipped with features such as timely reminders and alerts, ensuring regular dosing schedules. Their user-friendly design is driving their increasing popularity. Smart insulin pens can be easily attached to existing insulin pens, enhancing their functionality. The market for smart insulin pens is expanding due to their ability to provide timely alerts and reminders for correct insulin dosage, as well as monitoring missed doses, which is crucial for diabetic patients. These devices also help in maintaining a record of the patient's diabetes profile by monitoring blood sugar levels at specific times and dates. Additionally, they monitor insulin temperature ranges and expiry dates to ensure patient safety. However, the COVID-19 pandemic had a significant negative impact on the smart insulin pen market, as strict lockdown measures and restricted movement hindered access to laboratory testing and diabetic services, thereby limiting market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the global smart insulin pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Insulin Pens Market Segmental Analysis

The global smart insulin pens market is segmented based on product, connectivity type, indication, end-user, and region. By product, the market is segmented into smart insulin pens, and adaptors for conventional pens. By connectivity type, the market is segmented into bluetooth, and USB. By indication, the market is segmented into type 1 diabetes, type 2 diabetes. By end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and home care settings. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Smart Insulin Pens Market

The increasing prevalence of diabetes, coupled with the demands of modern life and a growing workload, has led to a surge in the demand for insulin products. In response to this trend, smart insulin pens have emerged as a popular solution. With people facing increasingly hectic schedules, keeping track of diabetes readings and insulin dosing schedules has become more challenging. Smart insulin pens offer a technological solution to these challenges, making it easier for individuals to manage their diabetes effectively. Furthermore, the rise in needle stick injuries has contributed to the growing popularity of smart insulin pens. Manufacturers in the smart insulin pen market are capitalizing on this trend by expanding their production globally, aiming to generate significant revenues in the coming years.

Restraints in the Global Smart Insulin Pens Market

The global market demand for smart insulin pens could be negatively impacted by their high cost. In regions like Africa, where healthcare infrastructure is often inadequate and reimbursement policies are poor, patients may face significant barriers to accessing modern medical devices like smart insulin pens. As a result, the affordability of these devices becomes a key concern, limiting their uptake among populations in developing countries. This issue highlights the importance of addressing cost barriers and improving access to innovative healthcare solutions for underserved communities worldwide.

Market Trends of the Global Smart Insulin Pens Market

The global smart insulin pens market is experiencing key industry trends driven by increasing advancements in research and development activities within the healthcare sector. As the number of diabetic patients worldwide continues to rise, there is a growing demand for innovative solutions to manage the condition effectively. Market manufacturers are responding to this demand by introducing new and innovative products in the smart insulin pens segment. These developments are projected to create lucrative growth opportunities for the market in the long run, as they address the evolving needs of diabetic patients and healthcare providers alike.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Smart Insulin Pens Market by Product

• Market Overview
• Smart insulin pen
• adaptors for conventional pen

Global Smart Insulin Pens Market by Connectivity typea

• Market Overview
• Bluetooth
• and USB

Global Smart Insulin Pens Market by Indication

• Market Overview
• Type 1 diabetes
• type 2 diabetes

Global Smart Insulin Pens Market by End-user

• Market Overview
• Hospitals & clinics
• ambulatory surgical centers
• home care settings

Global Smart Insulin Pens Market by Region

• Market Overview
• North America
• Europe
• Asia-Pacific
• Latin America
• and MEA

Global Smart Insulin Pens Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Emperra GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Companya
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Companion Medical Inc.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diabnexta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporationa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbHa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digital Medics Pty Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AGa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AGa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Common Sensing Inc.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InjexUK Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamesco Co., Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporationa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Co., Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wockhardt Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments